CYP24A1 and hypercalcemia disease: It is therefore conceivable that chronically elevated concentrations of 1,25(OH)2D in carriers of biallelic pathogenic variants of CYP24A1 may lead to depletion of calcium from bone thereby leading to osteopenia and maintenance of the hypercalcemia [3,31].